426 related articles for article (PubMed ID: 27994000)
41. Location of endometrial polyp and pregnancy rate in infertility patients.
Yanaihara A; Yorimitsu T; Motoyama H; Iwasaki S; Kawamura T
Fertil Steril; 2008 Jul; 90(1):180-2. PubMed ID: 17889854
[TBL] [Abstract][Full Text] [Related]
42. The bright edge of the endometrial polyp.
Caspi B; Appelman Z; Goldchmit R; Ashkenazi M; Haruvy Y; Hagay Z
Ultrasound Obstet Gynecol; 2000 Apr; 15(4):327-30. PubMed ID: 10895454
[TBL] [Abstract][Full Text] [Related]
43. Predictors of malignancy in endometrial polyps: a multi-institutional cohort study.
Litta P; Di Giuseppe J; Moriconi L; Delli Carpini G; Piermartiri MG; Ciavattini A
Eur J Gynaecol Oncol; 2014; 35(4):382-6. PubMed ID: 25118478
[TBL] [Abstract][Full Text] [Related]
44. Endometrial polyps: when to resect?
de Azevedo JM; de Azevedo LM; Freitas F; Wender MC
Arch Gynecol Obstet; 2016 Mar; 293(3):639-43. PubMed ID: 26305029
[TBL] [Abstract][Full Text] [Related]
45. Combination of endometrial thickness and time since menopause in predicting endometrial cancer in women with postmenopausal bleeding.
Bruchim I; Biron-Shental T; Altaras MM; Fishman A; Beyth Y; Tepper R; Aviram R
J Clin Ultrasound; 2004 Jun; 32(5):219-24. PubMed ID: 15124187
[TBL] [Abstract][Full Text] [Related]
46. Risk of cancer in symptomatic postmenopausal women with endometrial polyps at scan.
Kassab A; Trotter P; Fox R
J Obstet Gynaecol; 2008 Jul; 28(5):522-5. PubMed ID: 18850429
[TBL] [Abstract][Full Text] [Related]
47. Diagnosis and management of endometrial polyps: a critical review of the literature.
Salim S; Won H; Nesbitt-Hawes E; Campbell N; Abbott J
J Minim Invasive Gynecol; 2011; 18(5):569-81. PubMed ID: 21783430
[TBL] [Abstract][Full Text] [Related]
48. Flow differences between endometrial polyps and cancer: a prospective study using intravenous contrast-enhanced transvaginal color flow Doppler and three-dimensional power Doppler ultrasound.
Lieng M; Qvigstad E; Dahl GF; Istre O
Ultrasound Obstet Gynecol; 2008 Dec; 32(7):935-40. PubMed ID: 19035544
[TBL] [Abstract][Full Text] [Related]
49. What is the influence of cyclooxygenase-2 on postmenopausal endometrial polyps?
Pereira AK; Garcia MT; Pinheiro W; Ejzenberg D; Soares JM; Baracat EC
Climacteric; 2015; 18(4):498-502. PubMed ID: 25242379
[TBL] [Abstract][Full Text] [Related]
50. Sonographic Evaluation for Endometrial Polyps: The Interrupted Mucosa Sign.
Kamaya A; Yu PC; Lloyd CR; Chen BH; Desser TS; Maturen KE
J Ultrasound Med; 2016 Nov; 35(11):2381-2387. PubMed ID: 27629758
[TBL] [Abstract][Full Text] [Related]
51. Endometrial polyp size and polyp hyperplasia.
Lasmar BP; Lasmar RB
Int J Gynaecol Obstet; 2013 Dec; 123(3):236-9. PubMed ID: 24050479
[TBL] [Abstract][Full Text] [Related]
52. ESHRE/ESGE female genital tract anomalies classification system-the potential impact of discarding arcuate uterus on clinical practice.
Knez J; Saridogan E; Van Den Bosch T; Mavrelos D; Ambler G; Jurkovic D
Hum Reprod; 2018 Apr; 33(4):600-606. PubMed ID: 29514262
[TBL] [Abstract][Full Text] [Related]
53. Investigations for postmenopausal uterine bleeding: special considerations for endometrial volume.
Cho HJ; Lee ES; Lee JY; Hong SN; Ji YI; Kim HY; Kim A
Arch Iran Med; 2013 Nov; 16(11):665-70. PubMed ID: 24206410
[TBL] [Abstract][Full Text] [Related]
54. The clinical importance of polyp size measurement through two-dimensional saline infusion sonohysterography prior to hysteroscopic resection in predicting premalignant and malignant endometrial lesions.
Akış S; Kıran G; Göçmen A
Int J Gynaecol Obstet; 2022 Jun; 157(3):582-587. PubMed ID: 34510415
[TBL] [Abstract][Full Text] [Related]
55. The risk of premalignant and malignant pathology in endometrial polyps.
Bakour SH; Khan KS; Gupta JK
Acta Obstet Gynecol Scand; 2000 Apr; 79(4):317-20. PubMed ID: 10746849
[TBL] [Abstract][Full Text] [Related]
56. Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1?
Xuebing P; TinChiu L; Enlan X; Jing L; Xiaowu H
Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):198-203. PubMed ID: 21726930
[TBL] [Abstract][Full Text] [Related]
57. The oncogenic potential of endometrial polyps: a systematic review and meta-analysis.
Lee SC; Kaunitz AM; Sanchez-Ramos L; Rhatigan RM
Obstet Gynecol; 2010 Nov; 116(5):1197-205. PubMed ID: 20966706
[TBL] [Abstract][Full Text] [Related]
58. The risk of malignancy in uterine polyps: A systematic review and meta-analysis.
Uglietti A; Buggio L; Farella M; Chiaffarino F; Dridi D; Vercellini P; Parazzini F
Eur J Obstet Gynecol Reprod Biol; 2019 Jun; 237():48-56. PubMed ID: 31009859
[TBL] [Abstract][Full Text] [Related]
59. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients.
Cheng WF; Lin HH; Torng PL; Huang SC
Gynecol Oncol; 1997 Aug; 66(2):233-7. PubMed ID: 9264568
[TBL] [Abstract][Full Text] [Related]
60. [The value of ultrasonography in diagnosis of atypical endometrial hyperplasia in postmenopausal women].
Starczewski A; Brodowska A; Strojny K; Puchalski A; Mieczkowska E; Szydłowska I
Przegl Lek; 2005; 62(4):227-9. PubMed ID: 16229240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
